Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AN2728 for the Treatment of Psoriasis

Drug

AN 2728

Company / Licensee

Anacor Pharmaceuticals

Therapy Class

Topical anti-inflammatory compound

Product Description

Boron-based small-molecule compound

Current Indication

Psoriasis

Market Sector

Dermatology

Development Status

Phase IIb
Expand
Close
Close
Close

Go Top